Back
Biodexa Pharmaceuticals PLC 10K Form
Sell
20
BDRX
Biodexa Pharmaceuticals PLC
Last Price:
5.68
Seasonality Move:
-31.36%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BDRX News And Ratings
See the #1 stock for the next 7 days that we like better than BDRX
BDRX Financial Statistics
Sales & Book Value
Annual Sales: | $474.09K |
---|---|
Cash Flow: | $0 |
Price / Cash Flow: | 0 |
Annual Sales: | $30.44 |
Price / Book: | 0.3 |
Profitability
EPS (TTM): | -74.59720 |
---|---|
Net Income (TTM): | $-8.53M |
Gross Margin: | $-4.59M |
Return on Equity: | 0% |
Return on Assets: | 0% |
Biodexa Pharmaceuticals PLC Earnings Forecast
Key Biodexa Pharmaceuticals PLC Financial Ratios
- The Gross Profit Margin over the past 11 years for BDRX is -967.45%.
- The Selling, General & Administrative Expenses for BDRX have been equal to 1,139.63% of Gross Profit Margin.
- The Interest Expense is -0.58% of Operating Income.
- The Net Earning history of BDRX is -1,857.99% of Total Revenues.
- Per Share Earnings over the last 11 years have been positive in 6 years.
Biodexa Pharmaceuticals PLC Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | BDRX |
Website: | biodexapharma.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
BDRX Technical Analysis vs Fundamental Analysis
Sell
20
Biodexa Pharmaceuticals PLC (BDRX)
is a Sell
Is Biodexa Pharmaceuticals PLC a Buy or a Sell?
-
Biodexa Pharmaceuticals PLC stock is rated a Sell
The current Biodexa Pharmaceuticals PLC [BDRX] share price is $5.68. The Score for BDRX is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.